Company profile: Absolute Antibody
1.1 - Company Overview
Company description
- Provider of engineered and recombinant antibodies and related services for research and diagnostics, using a proprietary transient-transfection manufacturing platform to produce sequenced and engineered antibodies (AbsoluteAbs). Offerings include antibody sequencing, engineering and expression, primary antibodies, and recombinant antibodies against allergens, coronaviruses (including SARS-CoV-2), viruses, and DNA/RNA targets.
Products and services
- Primary Antibodies: Recombinant primary antibodies available in various species and formats for research and diagnostics, allowing selection of species origin and structural formats aligned to experimental needs
- Antibody Sequencing, Engineering & Expression: Proprietary transient transfection-based service that sequences, engineers, and expresses AbsoluteAbs for specific research needs, enabling fast, inexpensive production of sequenced and engineered antibodies
- Anti-Virus Antibodies: Multi-species recombinant antibodies targeting viral antigens, offered in multiple isotypes for studies of different viruses in research and diagnostics
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Absolute Antibody
WuXi XDC
HQ: China
Website
- Description: Provider of end-to-end CRDMO services for bioconjugates, including antibody-drug conjugates, spanning discovery, process development (scale-up, tech-transfer), analytical development, formulation/DP design, and GMP manufacturing of mAb intermediates and conjugations (antibodies and payload-linkers) from preclinical to commercial supply.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full WuXi XDC company profile →
Regulatory Compliance Associates
HQ: United States
Website
- Description: Provider of regulatory and quality consulting services for medical devices, pharmaceuticals, biologics, and compounding pharmacies. Offerings include regulatory affairs and submissions, compliance assurance, quality services, remediation strategy, FDA inspection preparation, cGMP guidance, and lab testing (biocompatibility, toxicology, sterility assurance, stability) to support product development and lifecycle needs.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Regulatory Compliance Associates company profile →
OctoPlus
HQ: The Netherlands
Website
- Description: Provider of specialty pharmaceutical expertise in the development of injectables. Based in a leading European bioscience park, the company is globally renowned and employs around 120 people representing over 20 nationalities.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full OctoPlus company profile →
Surface Ophthalmics
HQ: United States
Website
- Description: Provider of ophthalmic therapeutics leveraging the Klarity delivery vehicle, including SURF-100 topical eyedrops for chronic dry eye (Phase II), SURF-200 for acute dry eye (Phase II), SURF-201 Betamethasone 0.2% solution for post-cataract pain and inflammation (positive Phase II), and an MPA 0.1% chronic dry eye therapy ready for Phase III.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Surface Ophthalmics company profile →
Sanner
HQ: Germany
Website
- Description: Provider of primary plastic packaging systems for pharmaceuticals and dietary supplements, offering desiccant capsules (AdCap), canisters, packets (AdPack), plastic tubes with desiccant caps, desiccant closures with glass bottles, and closures for aluminum tubes. Solutions deliver moisture and odor absorption, protection against mechanical damage and unauthorized opening, compatibility with standard dosing systems; aluminum options are airtight, lightproof, and breakproof.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Sanner company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Absolute Antibody
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Absolute Antibody
2.2 - Growth funds investing in similar companies to Absolute Antibody
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Absolute Antibody
4.2 - Public trading comparable groups for Absolute Antibody
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →